These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8264123

  • 1. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered in various frequencies per week in Mycobacterium intracellulare-infected mice].
    Tomioka H, Sato K, Saito H, Dekio S, Hidaka T.
    Kekkaku; 1993 Nov; 68(11):683-6. PubMed ID: 8264123
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered at the different periods of infection in Mycobacterium intracellulare--infected mice].
    Tomioka H, Sato K, Saito H, Hidaka T.
    Kekkaku; 1993 Oct; 68(10):631-5. PubMed ID: 8255070
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [Abstract] [Full Text] [Related]

  • 10. [Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
    Shimizu T, Ogasawara K, Sato K, Sano C, Tomioka H.
    Kekkaku; 2001 May; 76(5):413-8. PubMed ID: 11449696
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K, Saito H, Ishii N, Goto M.
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model].
    Doi N.
    Kekkaku; 1998 Feb; 73(2):53-64. PubMed ID: 9545697
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Dec; 66(12):811-7. PubMed ID: 1784098
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
    Hirata T, Saito H, Tomioka H, Sato K, Jidoi J, Hosoe K, Hidaka T.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.